We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Georgia Capital Plc | LSE:CGEO | London | Ordinary Share | GB00BF4HYV08 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
16.00 | 1.22% | 1,330.00 | 1,328.00 | 1,334.00 | 1,338.00 | 1,314.00 | 1,314.00 | 5,458 | 13:04:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | 608.62M | 14.2620 | 0.94 | 570.98M |
TIDMCGEO
RNS Number : 8850D
Georgia Capital PLC
01 July 2021
London, 1 July 2021
Director/PDMR Shareholding - Correction
The following announcement replaces the 'Director/PDMR Shareholding' announcement released on 30 June 2021 at 17:17 under RNS Number 7304D.
All of the grants should be described as in respect of discretionary deferred shares except for the last, which is in respect of salary shares.
The corrected announcement is set out in full below.
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1. Details of the person discharging managerial responsibilities / person closely associated a) Name Irakli Gilauri 2. Reason for the notification a) Position / status PDMR, CEO and Chairman b) Initial notification / amendment Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Georgia Capital PLC b) LEI: 213800Q65T5GNBOW7H65 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of Nil cost options over ordinary shares of GBP0.01 each in instrument Georgia Capital PLC Identification Code N/A b) Nature of the transaction Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan. 25% of the shares will vest in each of the second, third, fourth and fifth years following the work year, subject to the terms of his service agreement. c) Price(s) and volume(s) Price(s) Volume(s) n/a 160,000 d) Aggregated information Aggregated volume Grant of 160,000 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan. Aggregated price n/a e) Dates of the transaction 29 June 2021 f) Place of the transaction Outside of a trading venue 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Avtandil Namicheishvili 2. Reason for the notification a) Position / status PDMR, Deputy CEO b) Initial notification / amendment Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Georgia Capital PLC b) LEI: 213800Q65T5GNBOW7H65 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of Nil cost options over ordinary shares of GBP0.01 each in instrument Georgia Capital PLC Identification Code N/A b) Nature of the transaction Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan. 25% of the shares will vest in each of the second, third, fourth and fifth years following the work year, subject to the terms of his service agreement. c) Price(s) and volume(s) Price(s) Volume(s) n/a 108,000 d) Aggregated information Aggregated volume Grant of 108,000 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan. Aggregated price n/a e) Dates of the transaction 29 June 2021 f) Place of the transaction Outside of a trading venue 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Giorgi Alpaidze 2. Reason for the notification a) Position / status PDMR, CFO b) Initial notification / amendment Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Georgia Capital PLC b) LEI: 213800Q65T5GNBOW7H65 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of Nil cost options over ordinary shares of GBP0.01 each in instrument Georgia Capital PLC Identification Code N/A b) Nature of the transaction Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan. 33.3% of the shares will vest in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. c) Price(s) and volume(s) Price(s) Volume(s) n/a 80,434 d) Aggregated information Aggregated volume Grant of 80,434 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan. Aggregated price n/a e) Dates of the transaction 29 June 2021 f) Place of the transaction Outside of a trading venue 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Nikoloz Gamkrelidze 2. Reason for the notification a) Position / status PDMR, CEO of Georgia Healthcare Group b) Initial notification / amendment Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Georgia Capital PLC b) LEI: 213800Q65T5GNBOW7H65 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of Nil cost options over ordinary shares of GBP0.01 each in
instrument Georgia Capital PLC Identification Code N/A b) Nature of the transaction Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan. 33.3% of the shares will vest in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. c) Price(s) and volume(s) Price(s) Volume(s) n/a 159,572 d) Aggregated information Aggregated volume Grant of 159,572 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan. Aggregated price n/a e) Dates of the transaction 29 June 2021 f) Place of the transaction Outside of a trading venue 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Nikoloz Gamkrelidze 2. Reason for the notification a) Position / status PDMR, CEO of Georgia Healthcare Group b) Initial notification / amendment Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Georgia Capital PLC b) LEI: 213800Q65T5GNBOW7H65 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of Nil cost options over ordinary shares of GBP0.01 each in instrument Georgia Capital PLC Identification Code N/A b) Nature of the transaction Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan. 25% of the salary shares will vest in each of the second, third, fourth and fifth years following the work year, subject to the terms of his service agreement. c) Price(s) and volume(s) Price(s) Volume(s) n/a 35,000 d) Aggregated information Aggregated volume Grant of 35,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan. Aggregated price n/a e) Dates of the transaction 29 June 2021 f) Place of the transaction Outside of a trading venue
Name of authorised official of issuer responsible for making notification:
Link Company Matters, Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAAXFEFEFEFA
(END) Dow Jones Newswires
July 01, 2021 11:13 ET (15:13 GMT)
1 Year Georgia Capital Chart |
1 Month Georgia Capital Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions